Emtricitabine And Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 42291-980

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 42291-980). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (980 30)

Packaging label for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, film-coated, oral dosage form, with strengths of 200 mg and 300 mg. The label shows the AvKARE brand, NDC 42291-980-30, package count of 30 tablets, and includes regulatory and storage information. The design features the AvKARE logo and a QR code.*

FDA Label Image

Emtricitabine Structure (Image 1)

Chemical structure of Emtricitabine, one of the active ingredients in Emtricitabine and Tenofovir Disoproxil Fumarate tablets.*

FDA Label Image

Tenofovir Disoproxil Fumarate (Image 2)

Chemical structure of Emtricitabine and Tenofovir Disoproxil Fumarate, the active ingredients in the oral film-coated tablet product by AvKARE, with strengths including 200 mg and 300 mg as indicated in the label set.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.